These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12952638)

  • 1. Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue.
    Hautot D; Pankhurst QA; Khan N; Dobson J
    Proc Biol Sci; 2003 Aug; 270 Suppl 1(Suppl 1):S62-4. PubMed ID: 12952638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Looking for biogenic magnetite in brain ferritin using NMR relaxometry.
    Gossuin Y; Hautot D; Muller RN; Pankhurst Q; Dobson J; Morris C; Gillis P; Collingwood J
    NMR Biomed; 2005 Nov; 18(7):469-72. PubMed ID: 16177954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ characterization and mapping of iron compounds in Alzheimer's disease tissue.
    Collingwood JF; Mikhaylova A; Davidson M; Batich C; Streit WJ; Terry J; Dobson J
    J Alzheimers Dis; 2005 Aug; 7(4):267-72. PubMed ID: 16131727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of magnetic iron compounds in Alzheimer's disease.
    Pankhurst Q; Hautot D; Khan N; Dobson J
    J Alzheimers Dis; 2008 Feb; 13(1):49-52. PubMed ID: 18334756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the structural form of iron in ferritin cores associated with progressive supranuclear palsy and Alzheimer's disease.
    Dobson J
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL49-50. PubMed ID: 11936873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetite biomineralization in the human brain.
    Kirschvink JL; Kobayashi-Kirschvink A; Woodford BJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7683-7. PubMed ID: 1502184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of age-related variations in biogenic magnetite levels in the human hippocampus.
    Dobson J
    Exp Brain Res; 2002 May; 144(1):122-6. PubMed ID: 11976766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Alzheimer's disease and formalin fixation on the different mineralised-iron forms in the human brain.
    van der Weerd L; Lefering A; Webb A; Egli R; Bossoni L
    Sci Rep; 2020 Oct; 10(1):16440. PubMed ID: 33020534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoscale biogenic iron oxides and neurodegenerative disease.
    Dobson J
    FEBS Lett; 2001 May; 496(1):1-5. PubMed ID: 11343696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic iron compounds in neurological disorders.
    Dobson J
    Ann N Y Acad Sci; 2004 Mar; 1012():183-92. PubMed ID: 15105266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping and characterization of iron compounds in Alzheimer's tissue.
    Collingwood J; Dobson J
    J Alzheimers Dis; 2006 Nov; 10(2-3):215-22. PubMed ID: 17119289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.
    Connor JR; Snyder BS; Beard JL; Fine RE; Mufson EJ
    J Neurosci Res; 1992 Feb; 31(2):327-35. PubMed ID: 1573683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to quantify different iron forms in ex-vivo human brain tissue.
    Kumar P; Bulk M; Webb A; van der Weerd L; Oosterkamp TH; Huber M; Bossoni L
    Sci Rep; 2016 Dec; 6():38916. PubMed ID: 27941952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material.
    Collingwood JF; Chong RK; Kasama T; Cervera-Gontard L; Dunin-Borkowski RE; Perry G; Pósfai M; Siedlak SL; Simpson ET; Smith MA; Dobson J
    J Alzheimers Dis; 2008 Jun; 14(2):235-45. PubMed ID: 18560134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients.
    Hautot D; Pankhurst QA; Morris CM; Curtis A; Burn J; Dobson J
    Biochim Biophys Acta; 2007 Jan; 1772(1):21-5. PubMed ID: 17097860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airborne Magnetite- and Iron-Rich Pollution Nanoparticles: Potential Neurotoxicants and Environmental Risk Factors for Neurodegenerative Disease, Including Alzheimer's Disease.
    Maher BA
    J Alzheimers Dis; 2019; 71(2):361-375. PubMed ID: 31381513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.
    Loeffler DA; Connor JR; Juneau PL; Snyder BS; Kanaley L; DeMaggio AJ; Nguyen H; Brickman CM; LeWitt PA
    J Neurochem; 1995 Aug; 65(2):710-24. PubMed ID: 7616227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.
    Connor JR; Menzies SL; St Martin SM; Mufson EJ
    J Neurosci Res; 1992 Jan; 31(1):75-83. PubMed ID: 1613823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.
    Everett J; Collingwood JF; Tjendana-Tjhin V; Brooks J; Lermyte F; Plascencia-Villa G; Hands-Portman I; Dobson J; Perry G; Telling ND
    Nanoscale; 2018 Jul; 10(25):11782-11796. PubMed ID: 29688240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biogenic magnetite formation through anaerobic biooxidation of Fe(II).
    Chaudhuri SK; Lack JG; Coates JD
    Appl Environ Microbiol; 2001 Jun; 67(6):2844-8. PubMed ID: 11375205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.